• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

GRACE 风险评分:加拿大急性冠脉综合征患者院内死亡率预测的性别有效性。

GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.

机构信息

University of Toronto, Toronto, ON, Canada.

University of Toronto, Toronto, ON, Canada; Terrence Donnelly Heart Centre, Division of Cardiology, St Michael's Hospital, Canadian Heart Research Centre, Toronto, ON, Canada.

出版信息

Int J Cardiol. 2017 Oct 1;244:24-29. doi: 10.1016/j.ijcard.2017.06.055. Epub 2017 Jun 15.

DOI:10.1016/j.ijcard.2017.06.055
PMID:28645803
Abstract

BACKGROUND

Although there are sex differences in management and outcome of acute coronary syndromes (ACS), sex is not a component of Global Registry of Acute Coronary Events (GRACE) risk score (RS) for in-hospital mortality prediction. We sought to determine the prognostic utility of GRACE RS in men and women, and whether its predictive accuracy would be augmented through sex-based modification of its components.

METHODS

Canadian men and women enrolled in GRACE and Canadian Registry of Acute Coronary Events were stratified as ST-segment elevation myocardial infarction (STEMI) or non-ST-segment elevation ACS (NSTE-ACS). GRACE RS was calculated as per original model. Discrimination and calibration were evaluated using the c-statistic and Hosmer-Lemeshow goodness-of-fit test, respectively. Multivariable logistic regression was undertaken to assess potential interactions of sex with GRACE RS components.

RESULTS

For the overall cohort (n=14,422), unadjusted in-hospital mortality rate was higher in women than men (4.5% vs. 3.0%, p<0.001). Overall, GRACE RS c-statistic and goodness-of-fit test p-value were 0.85 (95% CI 0.83-0.87) and 0.11, respectively. While the RS had excellent discrimination for all subgroups (c-statistics >0.80), discrimination was lower for women compared to men with STEMI [0.80 (0.75-0.84) vs. 0.86 (0.82-0.89), respectively, p<0.05]. The goodness-of-fit test showed good calibration for women (p=0.86), but suboptimal for men (p=0.031). No significant interaction was evident between sex and RS components (all p>0.25).

CONCLUSIONS

The GRACE RS is a valid predictor of in-hospital mortality for both men and women with ACS. The lack of interaction between sex and RS components suggests that sex-based modification is not required.

摘要

背景

尽管急性冠状动脉综合征(ACS)的治疗和预后存在性别差异,但全球急性冠状动脉事件注册(GRACE)风险评分(RS)并未将性别纳入院内死亡率预测因素。本研究旨在评估 GRACE RS 在男性和女性中的预后价值,以及是否可以通过对其组成部分进行基于性别的修正来提高其预测准确性。

方法

加拿大的男性和女性患者被纳入 GRACE 和加拿大急性冠状动脉事件注册研究,分为 ST 段抬高型心肌梗死(STEMI)或非 ST 段抬高型 ACS(NSTE-ACS)。按照原始模型计算 GRACE RS。使用 C 统计量和 Hosmer-Lemeshow 拟合优度检验分别评估区分度和校准度。采用多变量逻辑回归评估性别与 GRACE RS 组成部分之间的潜在交互作用。

结果

在整个队列(n=14422)中,女性未调整的院内死亡率高于男性(4.5% vs. 3.0%,p<0.001)。总体而言,GRACE RS 的 C 统计量和拟合优度检验 p 值分别为 0.85(95%CI 0.83-0.87)和 0.11。尽管 RS 对所有亚组均具有良好的区分能力(C 统计量>0.80),但 STEMI 患者中女性的区分能力低于男性[0.80(0.75-0.84)vs. 0.86(0.82-0.89),p<0.05]。拟合优度检验显示女性的拟合度较好(p=0.86),但男性较差(p=0.031)。性别与 RS 组成部分之间无显著交互作用(p 值均>0.25)。

结论

GRACE RS 是 ACS 男性和女性院内死亡率的有效预测因子。性别与 RS 组成部分之间无交互作用表明,无需进行基于性别的修正。

相似文献

1
GRACE risk score: Sex-based validity of in-hospital mortality prediction in Canadian patients with acute coronary syndrome.GRACE 风险评分:加拿大急性冠脉综合征患者院内死亡率预测的性别有效性。
Int J Cardiol. 2017 Oct 1;244:24-29. doi: 10.1016/j.ijcard.2017.06.055. Epub 2017 Jun 15.
2
Validation of the Global Registry of Acute Coronary Event (GRACE) risk score for in-hospital mortality in patients with acute coronary syndrome in Canada.加拿大急性冠状动脉综合征患者住院死亡率的全球急性冠状动脉事件注册研究(GRACE)风险评分的验证
Am Heart J. 2009 Sep;158(3):392-9. doi: 10.1016/j.ahj.2009.06.010.
3
Walking beyond the GRACE (Global Registry of Acute Coronary Events) model in the death risk stratification during hospitalization in patients with acute coronary syndrome: what do the AR-G (ACTION [Acute Coronary Treatment and Intervention Outcomes Network] Registry and GWTG [Get With the Guidelines] Database), NCDR (National Cardiovascular Data Registry), and EuroHeart Risk Scores Provide?在急性冠状动脉综合征患者住院期间的死亡风险分层中,超越 GRACE(全球急性冠状动脉事件注册)模型:AR-G(ACTION [急性冠状动脉治疗和干预结果网络]注册和 GWTG [遵循指南]数据库)、NCDR(国家心血管数据注册)和 EuroHeart 风险评分提供了什么?
JACC Cardiovasc Interv. 2012 Nov;5(11):1117-25. doi: 10.1016/j.jcin.2012.06.023.
4
Validity of the updated GRACE risk predictor (version 2.0) in patients with non-ST-elevation acute coronary syndrome.更新后的GRACE风险预测模型(2.0版)在非ST段抬高型急性冠状动脉综合征患者中的有效性。
Rev Port Cardiol. 2016 Jan;35(1):25-31. doi: 10.1016/j.repc.2015.07.010. Epub 2015 Dec 22.
5
Treatment and outcomes of patients with suspected acute coronary syndromes in relation to initial diagnostic impressions (insights from the Canadian Global Registry of Acute Coronary Events [GRACE] and Canadian Registry of Acute Coronary Events [CANRACE]).疑似急性冠状动脉综合征患者的治疗和转归与初始诊断印象的关系(来自加拿大急性冠状动脉事件全球登记处[GRACE]和加拿大急性冠状动脉事件登记处[CANRACE]的见解)。
Am J Cardiol. 2013 Jan 15;111(2):202-7. doi: 10.1016/j.amjcard.2012.09.018. Epub 2012 Nov 1.
6
Temporal changes in the management and outcome of Canadian diabetic patients hospitalized for non-ST-elevation acute coronary syndromes.加拿大非 ST 段抬高型急性冠脉综合征住院患者的管理和结局的时间变化。
Am Heart J. 2011 Aug;162(2):347-355.e1. doi: 10.1016/j.ahj.2011.05.020. Epub 2011 Jul 20.
7
Clinical trial--derived risk model may not generalize to real-world patients with acute coronary syndrome.来自临床试验的风险模型可能不适用于现实世界中的急性冠状动脉综合征患者。
Am Heart J. 2004 Dec;148(6):1020-7. doi: 10.1016/j.ahj.2004.02.014.
8
Predictive value of NT-proBNP for 30-day mortality in patients with non-ST-elevation acute coronary syndromes: a comparison with the GRACE and TIMI risk scores.NT-proBNP对非ST段抬高型急性冠状动脉综合征患者30天死亡率的预测价值:与GRACE和TIMI风险评分的比较
Vasc Health Risk Manag. 2016 Nov 21;12:471-476. doi: 10.2147/VHRM.S117204. eCollection 2016.
9
Anaemia to predict outcome in patients with acute coronary syndromes.贫血预测急性冠脉综合征患者的预后。
Arch Cardiovasc Dis. 2013 Jun-Jul;106(6-7):357-65. doi: 10.1016/j.acvd.2013.04.004. Epub 2013 Jun 24.
10
Validation of the 6-Month GRACE Score in Predicting 1-Year Mortality of Patients With Acute Coronary Syndrome Admitted to the Arabian Gulf Hospitals.6个月GRACE评分对入住阿拉伯湾医院的急性冠状动脉综合征患者1年死亡率预测的验证
Angiology. 2017 Mar;68(3):251-256. doi: 10.1177/0003319716659179. Epub 2016 Jul 20.

引用本文的文献

1
Incorporating the STOP-BANG questionnaire improves prediction of cardiovascular events during hospitalization after myocardial infarction.纳入 STOP-BANG 问卷可改善心肌梗死后住院期间心血管事件的预测。
Sci Rep. 2025 May 31;15(1):19180. doi: 10.1038/s41598-025-03882-z.
2
RURUS SURYAWAN Score: A Novel Scoring System to Predict 30-Day Mortality for Acute Myocardial Infarction Undergoing Primary Percutaneous Coronary Intervention.鲁鲁斯·苏里亚万评分:一种预测接受直接经皮冠状动脉介入治疗的急性心肌梗死患者30天死亡率的新型评分系统。
J Clin Med. 2025 Mar 4;14(5):1716. doi: 10.3390/jcm14051716.
3
Bridging Care Gaps for Older Women Undergoing Percutaneous Coronary Intervention.
为行经皮冠状动脉介入治疗的老年女性患者搭建护理桥梁。
Interv Cardiol Clin. 2025 Jan;14(1):69-79. doi: 10.1016/j.iccl.2024.08.006.
4
The Predictive Role of Cardiac Troponin Elevation Ratio Combined With Heart Function Index Model in the Prognosis of Non-ST-Segment Elevation Myocardial Infarction Patients.心肌肌钙蛋白升高比值联合心功能指标模型在非ST段抬高型心肌梗死患者预后中的预测作用
Cardiol Res. 2024 Aug;15(4):246-252. doi: 10.14740/cr1639. Epub 2024 Jul 18.
5
Can Artificial Intelligence Change our Interpretation of Cardiovascular Risk Scores?人工智能能改变我们对心血管风险评分的解读吗?
Arq Bras Cardiol. 2024 Jul 19;121(4):e20240280. doi: 10.36660/abc.20240280.
6
The Impact of Gender and Race When Using the GRACE ACS Score to Predict Mortality.使用GRACE急性冠状动脉综合征评分预测死亡率时性别和种族的影响。
HCA Healthc J Med. 2023 Jun 28;4(3):235-242. doi: 10.36518/2689-0216.1426. eCollection 2023.
7
The GRACE risk score in patients with ST-segment elevation myocardial infarction and concomitant COVID-19.ST段抬高型心肌梗死合并新型冠状病毒肺炎患者的GRACE风险评分
Arch Med Sci Atheroscler Dis. 2022 Aug 10;7:e116-e123. doi: 10.5114/amsad/152107. eCollection 2022.
8
Systematic review and meta-analysis of prognostic models in Southeast Asian populations with acute myocardial infarction.东南亚急性心肌梗死患者预后模型的系统评价与荟萃分析。
Front Cardiovasc Med. 2022 Jul 26;9:921044. doi: 10.3389/fcvm.2022.921044. eCollection 2022.
9
External validation of the GRACE risk score and the risk-treatment paradox in patients with acute coronary syndrome.GRACE 风险评分在急性冠状动脉综合征患者中的外部验证及风险-治疗悖论。
Open Heart. 2022 Mar;9(1). doi: 10.1136/openhrt-2022-001984.
10
Comparison of GRACE and TIMI risk scores in the prediction of in-hospital and long-term outcomes among East Asian non-ST-elevation myocardial infarction patients.比较 GRACE 和 TIMI 风险评分在预测东亚非 ST 段抬高型心肌梗死患者住院期间和长期结局中的作用。
BMC Cardiovasc Disord. 2022 Jan 7;22(1):4. doi: 10.1186/s12872-021-02311-z.